Cadmium induces p53-dependent apoptosis in human prostate epithelial cells

"Cadmium, a widespread toxic pollutant of occupational and environmental concern, is a known human carcinogen. The. prostate is a potential target for cadmium carcinogenesis, although the underlying mechanisms are still unclear.. Furthermore, cadmium may induce cell death by apoptosis in various cell types, and it has been hypothesized that a key. factor in cadmium-induced malignant transformation is acquisition of apoptotic resistance. We investigated the in vitro. effects produced by cadmium exposure in normal or tumor cells derived from human prostate epithelium, including RWPE-. 1 and its cadmium-transformed derivative CTPE, the primary adenocarcinoma 22Rv1 and CWR-R1 cells and LNCaP, PC-3 and. DU145 metastatic cancer cell lines. Cells were treated for 24 hours with different concentrations of CdCl2 and apoptosis, cell. cycle distribution and expression of tumor suppressor proteins were analyzed. Subsequently, cellular response to cadmium. was evaluated after siRNA-mediated p53 silencing in wild type p53-expressing RWPE-1 and LNCaP cells, and after adenoviral. p53 overexpression in p53-deficient DU145 and PC-3 cell lines. The cell lines exhibited different sensitivity to cadmium, and. 24-hour exposure to different CdCl2 concentrations induced dose- and cell type-dependent apoptotic response and. inhibition of cell proliferation that correlated with accumulation of functional p53 and overexpression of p21 in wild type. p53-expressing cell lines. On the other hand, p53 silencing was able to suppress cadmium-induced apoptosis. Our results. demonstrate that cadmium can induce p53-dependent apoptosis in human prostate epithelial cells and suggest p53. mutation as a possible contributing factor for the acquisition of apoptotic resistance in cadmium prostatic carcinogenesis."